Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Related Keywords

United States ,Redwood City ,California ,American ,Angie Mccabe ,Kevin Thornal ,Erika Petersen ,University Of Arkansas ,Prnewswire Nevro Corp ,Facebook ,Investor Relations Corporate Communications ,Instagram ,World Health Organization ,Nevro Corp ,Diabetes Research ,Linkedin ,American Diabetes Association ,Worldwide Initiative For Diabetes Education ,Worldwide Initiative ,Diabetes Education ,Painful Diabetic Neuropathy ,Virtual Global ,Clinical Practice ,David Caraway ,Investor Relations ,Painful Diabetic Peripheral ,Suboptimal Treatment ,Diabetic Peripheral Neuropathic Pain ,